Neonatal & Pediatric Clinical Pharmacist
Mar 31, 2026
•
1 min read
~89,000 bottles of Children's Ibuprofen recalled after reports of foreign particles
Mar 24, 2026
Federal court restores pre-January 2026 pediatric vaccine schedule
Mar 17, 2026
4 min read
Nearly 20,000 U.S. emergency department visits occur each year for oral prescription medication ingestions in children younger than 6 years. Clonidine and buprenorphine account for the highest hospitalization estimates.
Mar 10, 2026
A 10-day hydrocortisone taper given at 14-28 days of life in ventilated preterm infants did not significantly impact functional outcomes at early school age compared with placebo.
Mar 3, 2026
Six weeks of once-daily intranasal saline resolved symptoms in 29.5% of children 3-12 years old, with cumulative resolution near 50% after 12 weeks. Adding mometasone after nonresponse did not improve outcomes.
Feb 24, 2026
In 44 pediatric cardiac patients 0-24 months of age (median 2.1 months), the median clopidogrel dose associated with therapeutic P2Y12 reaction unit (PRU) values was 0.22 mg/kg/day (IQR 0.19-0.34). This conflicts with the fixed 0.2 mg/kg/day recommended by the PICOLO trial.
Feb 17, 2026
Explainable machine learning models achieved higher simulated therapeutic alignment than standard weight-based dosing in young children, though findings remain exploratory.
Feb 10, 2026
5 min read
Percentage of term and late-preterm infants who did not receive vitamin K in the U.S. increased from 2.9% to 5.2% between 2017 and 2024, with refusal trends beginning prior to the COVID-19 pandemic.
Feb 3, 2026
Pediatric practice is shifting from trough-based monitoring to AUC/MIC targets of 400-600 mg·h/L, with higher initial doses and earlier monitoring to optimize exposure and reduce nephrotoxicity.
Jan 27, 2026
Propranolol, esmolol, and captopril were the most commonly used agents in preterm neonates, with dosing strategies varying by gestational age and clinical stability.
Jan 20, 2026
Placebo minitablets mixed with soft food are acceptable for many children 9 months to 7 years, with swallowability improving with age and higher soft-food volumes often preferred.
Jan 13, 2026
Intramuscular aluminum forms a slow-release depot and is efficiently renally cleared, with no detectable rise in serum aluminum levels and no credible association with autism, asthma, or autoimmune disease.
Jan 6, 2026
2025 updates include higher endotracheal epinephrine dosing while access is obtained, mandate a fixed saline flush, and formally recognize IO access.
